Sonic Healthcare Sells $250 Million of 10-Year Bonds to Investors in U.S.

Sonic Healthcare Ltd., the largest provider of medical tests in Australia, sold $250 million of 10- year bonds to private investors in the U.S.

The 5.1 percent notes were priced to yield 215 basis points more than Treasuries, the Sydney-based company said in a statement released to the Australian stock exchange. Proceeds will be used to repay bank loans and fund growth, it said.

Sonic has spent more than $1.8 billion on acquisitions in the past five years, according to data compiled by Bloomberg. The company last month agreed to buy CBLPath Inc. for $123.5 million, saying the deal will boost sales and cut costs.

Sonic sold $250 million of seven- and 10-year bonds to U.S. private investors in November 2009, pricing the notes at a 225 basis-point spread, according to a regulatory filing at the time. The company has A$482 million ($471 million) of loan facilities maturing next year, Bloomberg data show.

To contact the reporter on this story: Lisa Pham in Sydney at lpham14@bloomberg.net.

To contact the editor responsible for this story: Will McSheehy at wmcsheehy@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.